Pregabalin in Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy

Abstract

This is the first reported placebo-controlled trial of pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy. Although the primary endpoint was not met, pregabalin was associated with clinically relevant improvements versus placebo in this difficult-to-treat population.